Detail akcie OptiBiotix Health online

Business Summary: OptiBiotix Health Plc is a life sciences company. The Company is engaged in the development of microbial strains, compounds, and formulations, which are used as active ingredients and supplements. It is focused on the development of products which reduce hunger and food cravings, enhance the gut microbiome, and provide a healthy substitute for sugar. It is also developing its own range of consumer supplements and health products. Its areas of focus include obesity, cardiovascular health, and diabetes. Its products include SlimBiome, CholBiome, SweetBiotix, WellBiome, OptiBiotics and SlimBiome X3. SlimBiome offers a natural, scientifically supported, non-pharmaceutical approach to reducing hunger and cravings. CholBiome contains Lactobacillus plantarum LPLDL as the only active ingredient, focusing on healthy cholesterol maintenance and delivering tangible health benefits. SweetBiotix is a zero or low-calorie, prebiotic, and a smarter alternative to sugar and existing sweeteners.
Financial Summary: BRIEF: For the six months ended 30 June 2025, OptiBiotix Health PLC revenues increased from L276K to L557K. Net loss decreased 58% to L1.2M. Revenues reflect India segment increase from L0K to L114K, Australia segment increase from L8K to L107K, United States segment increase from L0K to L56K. Basic Earnings per Share excluding Extraordinary Items increased from -L0.03 to -L0.01.